Annual Total Liabilities
$91.98 M
-$57.58 M-38.50%
December 31, 2023
Summary
- As of February 7, 2025, RLAY annual total liabilities is $91.98 million, with the most recent change of -$57.58 million (-38.50%) on December 31, 2023.
- During the last 3 years, RLAY annual total liabilities has risen by +$55.44 million (+151.74%).
- RLAY annual total liabilities is now -83.96% below its all-time high of $573.51 million, reached on December 31, 2019.
Performance
RLAY Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$91.25 M
+$448.00 K+0.49%
September 1, 2024
Summary
- As of February 7, 2025, RLAY quarterly total liabilities is $91.25 million, with the most recent change of +$448.00 thousand (+0.49%) on September 1, 2024.
- Over the past year, RLAY quarterly total liabilities has dropped by -$37.33 million (-29.03%).
- RLAY quarterly total liabilities is now -84.09% below its all-time high of $573.51 million, reached on December 31, 2019.
Performance
RLAY Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RLAY Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.5% | -29.0% |
| 3 y3 years | +151.7% | -9.2% |
| 5 y5 years | -83.0% | - |
RLAY Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.5% | at low | -46.0% | +0.5% |
| 5 y | 5-year | -84.0% | +151.7% | -84.1% | +161.9% |
| alltime | all time | -84.0% | +151.7% | -84.1% | +161.9% |
Relay Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $91.25 M(+0.5%) |
| Jun 2024 | - | $90.81 M(-5.1%) |
| Mar 2024 | - | $95.68 M(+4.0%) |
| Dec 2023 | $91.98 M(-38.5%) | $91.98 M(-28.5%) |
| Sep 2023 | - | $128.59 M(-15.3%) |
| Jun 2023 | - | $151.90 M(-1.5%) |
| Mar 2023 | - | $154.15 M(+3.1%) |
| Dec 2022 | $149.55 M | $149.55 M(-11.5%) |
| Sep 2022 | - | $168.95 M(+53.9%) |
| Jun 2022 | - | $109.78 M(+1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $107.91 M(-2.5%) |
| Dec 2021 | $110.64 M(+202.8%) | $110.64 M(+10.1%) |
| Sep 2021 | - | $100.53 M(+4.9%) |
| Jun 2021 | - | $95.87 M(+148.6%) |
| Mar 2021 | - | $38.56 M(+5.5%) |
| Dec 2020 | $36.54 M(-93.6%) | $36.54 M(-4.2%) |
| Sep 2020 | - | $38.16 M(-93.3%) |
| Jun 2020 | - | $573.43 M(+1545.7%) |
| Mar 2020 | - | $34.84 M(-93.9%) |
| Dec 2019 | $573.51 M(+6.3%) | $573.51 M |
| Dec 2018 | $539.54 M | - |
FAQ
- What is Relay Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Relay Therapeutics?
- What is Relay Therapeutics annual total liabilities year-on-year change?
- What is Relay Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Relay Therapeutics?
- What is Relay Therapeutics quarterly total liabilities year-on-year change?
What is Relay Therapeutics annual total liabilities?
The current annual total liabilities of RLAY is $91.98 M
What is the all time high annual total liabilities for Relay Therapeutics?
Relay Therapeutics all-time high annual total liabilities is $573.51 M
What is Relay Therapeutics annual total liabilities year-on-year change?
Over the past year, RLAY annual total liabilities has changed by -$57.58 M (-38.50%)
What is Relay Therapeutics quarterly total liabilities?
The current quarterly total liabilities of RLAY is $91.25 M
What is the all time high quarterly total liabilities for Relay Therapeutics?
Relay Therapeutics all-time high quarterly total liabilities is $573.51 M
What is Relay Therapeutics quarterly total liabilities year-on-year change?
Over the past year, RLAY quarterly total liabilities has changed by -$37.33 M (-29.03%)